Completed Research
A Phase 3, Randomized, Observer-Blind, Controlled, Multicenter, Clinical Study to Evaluate Immunogenicity and Safety of a High-Dose MF59-Adjuvanted Quadrivalent Subunit Cell-derived Influenza Vaccine (aQIVc HD) in Comparison with a Non-adjuvanted Quadrivalent Recombinant Influenza Vaccine (QIVr) and an MF59-Adjuvanted Quadrivalent Subunit Egg-derived Influenza Vaccine (aQIV), in Adults Aged 50 Years and Older
Principal Investigator — Dr. Charles Y. Yu
Status — Completed (March 2025)
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease
Principal Investigator — Dr. Charles Y. Yu
Status — Completed (August 2025)
A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine Compared to a Quadrivalent Influenza Vaccine in Adults ≥65 Years of Age
Principal Investigator — Dr. Charles Y. Yu
Status — Completed (May 2026)
Comparative Validation and Concordance of Qiastat Dx and Biofire Respiratory Panel for SARS Coverage 2 detection in clinical respiratory samples
A phase 2, partially-blinded, randomised Study assessing the safety and efficacy of TBAJ876 or bedaquiline, in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear- positive pulmonary tuberculosis
Principal Investigator — Dr. Charles Y. Yu
Status — Completed (September 2026)